What is UTHR's health score?

UNITED THERAPEUTICS Corp (UTHR) has a TradeApes health score of 73 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is UTHR's estimated fair value?

Based on our 5-year discounted cash flow model, UNITED THERAPEUTICS Corp's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is UTHR undervalued or overvalued?

Our model currently rates UTHR as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

UNITED THERAPEUTICS Corp (UTHR)

Healthcare Overvalued low healthy

$535.67

Updated: 2026-07-18

TradeApes Score

Financial Strength

90 Strong

Operating Trend

68 Healthy

Relative Value

63 Healthy

Capital Allocation

65 Healthy

Risk Management

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

Industry Related Stocks

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Aardvark Therapeutics, Inc. (AARD) Abivax S.A. (AAVXF) Ascend Wellness Holdings, Inc. (AAWH) AbbVie Inc. (ABBV) AbCellera Biologics Inc. (ABCL)

See all Healthcare stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.